A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, Four-Period Crossover Study To Evaluate the Effect of Gepotidacin on Cardiac Conduction as Assessed by 12-Lead Electrocardiogram in Healthy Volunteers

Gepotidacin is a novel, first-in-class triazaacenaphthylene antibiotic in development for treatment of conventional and biothreat infections. This was a single-dose, crossover thorough QT study in healthy subjects who were administered intravenous (i.v.) gepotidacin as a therapeutic (1,000-mg) dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Mohammad, Zhou, Meijian, Tiffany, Courtney, Dumont, Etienne, Darpo, Borje
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404516/
https://www.ncbi.nlm.nih.gov/pubmed/28223381
http://dx.doi.org/10.1128/AAC.02385-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404516/
https://www.ncbi.nlm.nih.gov/pubmed/28223381
http://dx.doi.org/10.1128/AAC.02385-16

Ejemplares similares